Resources | NITAG RESOURCE CENTER

2022 ∙ ATAGI

ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.1) COVID-19 vaccine

2022 ∙ ATAGI

ATAGI recommendations for a booster dose of the paediatric Pfizer COVID-19 vaccine in children aged 5 to 11 years

2022 ∙ ATAGI

COVID-19 vaccination – Guidance on myocarditis and pericarditis after COVID-19 vaccines

2022 ∙ ATAGI

ATAGI statement on use of the Moderna bivalent Original/Omicron vaccine

2022 ∙ ATAGI

ATAGI clinical guidance on vaccination against Monkeypox

2022 ∙ ATAGI

Novavax vaccine for adolescents aged 12-17 years

2022 ∙ ATAGI

ATAGI recommendations for use of Pfizer COVID-19 vaccine as a booster dose in adolescents aged 16-17 years

2022 ∙ ATAGI

ATAGI recommendations on the use of a booster dose of COVID-19 vaccine

2022 ∙ ATAGI

ATAGI statement on defining 'up-to-date' status for COVID-19 vaccination

2022 ∙ ATAGI

ATAGI statement on recommendations on a winter booster dose of COVID-19 vaccine